On April 6, 2016, Gary Herick, was appointed by a majority of the Board of Directors as acting Chief Executive Officer, Chief Financial Officer, President, and a Director of CannaPharmaRx, Inc. Effective April 6, 2016, Mr. Herick is the sole director of the Company. Effective April 6, 2016 James Smeeding resigned as the Interim President of the Company. Effective April 6, 2016 Mathew Sherwood resigned as the Vice President of Product Development and Interim Secretary of the Company.

Effective April 6, 2016 David Pohl resigned as a Director of the Company. Effective April 6, 2016 Steven Rule resigned as a Director of the Company. Effective April 6, 2016 Elie Khalife resigned as a Director of the Company.

Effective April 6, 2016 Robert Liess resigned as a Director of the Company.